Floreo Stock

Floreo develops therapy virtual reality for people with autism.

Sign up today and learn more about Floreo Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Floreo Stock

Floreo, a venture and NIH backed startup, leverages the power of virtual reality to provide safe, immersive, repeatable, and affordable social and communication therapy that is fun and engaging for the user, while allowing a supervising adult to monitor and track the user’s progress. The company is currently piloting Floreo at a special education school for children on the autism spectrum, a large ABA therapy company, and through a partnership with the Center for Autism Research at Children’s Hospital of Philadelphia. Floreo believes in building a premium science-backed and tested product. To that end, the company has established partnerships with leading research, academic, therapy, and civic partners.

Funding History

November 2017$2.1M
October 2022$10.0M

Management

Investor

Indu Navar

CEO

Vijay Ravindran

Investor

Felix Anthony

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo